MONTREAL, QUEBEC -- (Marketwire) -- 11/23/12 -- ZoomMed Inc. (TSX VENTURE:ZMD), is dedicated to the development and marketing of a wide range and essential IT solutions for healthcare professionals across North America. ZoomMed builds and operates the e-Pic Communication Platform, a clinical interoperable information exchange network between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations, laboratories, specialized clinics private insurers, employers and others.

ZoomMed held its Annual and Special Meeting of Shareholders as at November 23, 2012.

The purpose of the meeting was:

--  To receive the consolidated financial statements of ZoomMed for the
    fiscal year ended May 31, 2012 and the independent auditors' report; 
    
--  To elect the board of directors composed of: 
    
    --  Micheline Luneau 
    --  Andre Marmet 
    --  Yves Marmet 
    --  Nicolas Matziorinis 
    --  Bruno Floriani 
    --  Marie-Helene Pinard 
    --  Robert Powell 
        
--  To appoint Mazars Harel Drouin as the independent auditor and authorize
    the directors to fix their remuneration; 
    
--  To approve ZoomMed's stock option plan, a 10% rolling stock option plan;

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.